Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11263748 Determining biomarkers from histopathology slide images

Patent 11263748 was granted and assigned to Tempus Labs (company) on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Tempus Labs (company)

Current Assignee

Tempus Labs (company)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

March 1, 2022

Patent Application Number

17169162

Date Filed

February 5, 2021

Patent Citations

US Patent 10426442 Adaptive image processing in assisted reproductive imaging modalities

US Patent 10049450 High-throughput adaptive sampling for whole-slide histopathology image analysis

US Patent 10078895 Prediction of recurrence of non-small cell lung cancer with tumor infiltrating lymphocyte (TIL) graphs

US Patent 10102418 Adaptive classification for whole slide tissue segmentation

US Patent 10699163 Methods and apparatus for classification

Patent Citations Received

US Patent 11935152 Determining biomarkers from histopathology slide images

0

US Patent 11682098 Determining biomarkers from histopathology slide images

0

Patent Primary Examiner

Patent abstract

A generalizable and interpretable deep learning model for predicting biomarker status and biomarker metrics from histopathology slide images is provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11263748 Determining biomarkers from histopathology slide images

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool